Keyphrases
Mexico
100%
Klebsiella Pneumoniae (K. pneumoniae)
60%
Escherichia Coli
53%
Antibiotic Resistance
44%
Pseudomonas Aeruginosa (P. aeruginosa)
42%
Uropathogenic Escherichia Coli
42%
High Resistance
35%
Carbapenem Resistance
35%
INVIFAR
31%
Genotype
29%
Antimicrobial Resistance
28%
Cefepime
27%
Carbapenemase
26%
Sonora
24%
Carbapenemase Genes
23%
Baumannii
21%
MIRU-VNTR
21%
Age Groups
21%
Uropathogenic E. Coli
21%
Drug Resistance
21%
Microorganisms
19%
Meropenem
19%
Acinetobacter Baumannii (A. baumannii)
19%
Staphylococcus Aureus
18%
Extended-spectrum-lactamase
17%
Gram-negative
16%
Fluoroquinolones
16%
Urinary Tract Infection
16%
Antimicrobial Resistance Surveillance
15%
Antibiotics
13%
Resistance Genotype
13%
Resistance Factor
13%
Pediatric Population
13%
Trimethoprim-sulfamethoxazole (TMP-SMX)
13%
Gentamicin
12%
Clinical Specimens
11%
E. Coli Pneumonia
11%
Resistant Isolate
11%
Mycobacterium Bovis
10%
Bacterial Inhibition
10%
Resistance Phenotypes
10%
Care Groups
10%
Healthcare Institutions
10%
Location of Care
10%
Active Surveillance
10%
Intensive Care Unit
10%
Blood Fluid
10%
Pleural Fluid
10%
Hybrid Pathotype
10%
Tuberculosis Diagnosis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Antimicrobial Resistance
67%
Escherichia coli
61%
Pseudomonas aeruginosa
37%
Carbapenemase
34%
Drug Resistance
31%
Infectious Agent
29%
Cefepime
26%
Microorganism
23%
Carbapenem Resistance
21%
Uropathogenic Escherichia Coli
21%
Extended Spectrum Beta Lactamase
19%
Acinetobacter Baumannii
19%
Antibiotics
19%
Staphylococcus aureus
18%
Carbapenem Derivative
18%
Amoxicillin
17%
Prevalence
16%
Klebsiella pneumoniae
16%
Meropenem
16%
Gentamicin
14%
Urinary Tract Infection
14%
Quinolone Derivative
14%
Diseases
13%
Ceftazidime
13%
Levofloxacin
12%
Penicillinase
11%
Gamma Interferon
10%
Mycobacterium Tuberculosis
10%
Cotrimoxazole
10%
Fructose 6 Phosphate
10%
Lactobacillus
10%
Coronavirinae
10%
Polyacrylamide
10%
Controlled Release
10%
Imipenem
10%
Erythromycin
9%
Multidrug Resistance
8%
Enterobacteriaceae
7%
Carbapenem
7%
Oxacillin
7%
Nitrofurantoin
7%
Clavulanic Acid
7%
Sultamicillin
7%
Ampicillin
7%
Piperacillin Plus Tazobactam
6%
Voriconazole
6%
Caspofungin
6%
Candida albicans
6%
Enterococcus faecium
5%
Ciprofloxacin
5%
Immunology and Microbiology
Antimicrobial Resistance
70%
Escherichia coli
67%
Uropathogenic Escherichia Coli
42%
Pseudomonas aeruginosa
39%
Urinary Tract
32%
Drug Resistance
31%
Infectious Agent
27%
Klebsiella pneumoniae
24%
Prevalence
24%
Variable Number of Tandem Repeat
21%
Staphylococcus aureus
16%
Acinetobacter Baumannii
16%
Microorganism
12%
Mycobacterium bovis
10%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
10%
Cladistics
10%
Norovirus
10%
Mycobacterium Tuberculosis
10%
COVID-19
10%
Wild Type
10%
Type Strain
10%
Morphotype
10%
Lactobacillus
10%
Cerebrospinal Fluid
10%
Plasmid
9%
Data Analysis Software
9%
Multidrug Resistance
8%
Pathogenicity Island
8%
Enterobacteriaceae
7%
Antibiotic Sensitivity
7%
Extraintestinal Pathogenic Escherichia Coli
6%
Diarrheagenic Escherichia Coli
6%
Candida albicans
6%
Lactic Acid Bacterium
5%
Enterococcus faecium
5%